This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Waters Expands UNIFI Solutions With Three New Applications: Glycans, Forensic Toxicology And Natural Products

Stocks in this article: WAT

MILFORD, Mass., Jan. 29, 2014 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced three new UNIFI ® Scientific Information System solutions: the Waters ® Glycan Application Solution with UNIFI, Forensic Toxicology Screening Application Solution with UNIFI, and the Natural Products Application Solution with UNIFI. Each new application features a proprietary comprehensive library of relevant molecules.

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)

"Not only does our most recent release of the Waters UNIFI Scientific Information System demonstrate improved software performance such as customizable workflows capabilities and multi-user workgroup server-based connectivity, but new users will benefit from access to powerful library databases for their specific applications," said Dr. Rohit Khanna, Vice President of Informatics and Worldwide Marketing for Waters. "These application specific libraries enable our customers to optimize application methods for improved robustness, performance, and processing speed for the quantification of known chemical compounds and the identification of new species."

The Glycan Application Solution with UNIFI™  features an extensive N-glycan Glucose Unit (GU) reference database that was developed in collaboration with the National Institute for Bioprocessing Research and Training (NIBRT).  The Waters Glycan GU Library, used along with Waters' robust and bioseparations-focused analytical technologies to characterize glycosylation, enables biopharmaceutical laboratories to deliver well-characterized biotherapeutics from discovery through development and QC operations.  The solution facilitates routine assignment of N-linked glycan structures, and enables profiling of released glycans for individual sample analysis and expedites multi-batch comparability studies for either innovator biotherapeutics or biosimilars.  The system solution consists of the ACQUITY UltraPerformance LC ® (UPLC ®) H-Class System, an ACQUITY UPLC ® Fluorescence (FLR) Detector, the Xevo ® G2-S QTof Mass Spectrometer, Waters' application-tested bioseparation column chemistries, and analytical glycan standards used for system familiarization training, GU-retention time calibration and routine glycan system function checks. This new Glycan Application Solution with UNIFI complements intact protein analysis and peptide mapping applications that are also available within the Biopharmaceutical Platform Solution with UNIFI.

Waters Forensic Toxicology Screening Application Solution with UNIFI  was devised with direct input from forensic scientists within active forensic toxicology laboratories. A complete toxicology solution, the platform integrates chromatography method, mass spec and software to enable a robust, end-to-end solution that requires minimal or no method development. The software includes a comprehensive database of compounds of toxicological interest which can easily be extended to address 'unknown' analytes that may be germane to the evidence. Furthermore, UNIFI reporting capabilities present forensic sample analysis results in a meaningful and relevant manner to improve the forensic laboratory workflow, output and turnaround time. Lastly, the UNIFI software security is well tailored to meet the stringent chain-of-custody standards of forensic toxicology laboratories. In addition to the UNIFI software platform, the application solution consists of the ACQUITY UltraPerformance LC ® (UPLC ®) I-Class, the Xevo ® G2-S QTof mass spectrometer and Waters' application-tested HSS column chemistries.

Also built upon the Waters Screening Platform Solution, the Natural Products Application Solution with UNIFI enables laboratories to readily move from sample extract to product knowledge using a sensitive and accurate-mass analytical platform integrated with fit-for-purpose workflows and reporting. The solution features a "Traditional Medicines" library including all the herbs detailed in the 2010 Chinese Pharmacopeia. The integration of data acquisition and processing with the Traditional Medicine library provides a simple, efficient process to effectively facilitate the identification and comparison of chemical ingredients from complex natural product samples. This greatly improves productivity and reduces the demands for operator's technical expertise level. The application solution consists of the ACQUITY UltraPerformance LC ® (UPLC ®) I-Class System, an ACQUITY UPLC TUV Detector, the Xevo ® G2-S QTof mass spectrometer, Waters' application-tested High Strength Silica (HSS) column chemistries and application-specific analytical standards.

These three new application solutions can be deployed and configured to meet the needs and offer unique UNIFI capabilities to multi-user, server-based workgroups for the capture, storage, and management of analytical LC, LC/MS, and LC/MS/MS data. Additionally, UNIFI manages and stores exponentially larger dataset files with improved robustness, performance and processing speed which is a major step forward for advancing UNIFI as an enterprise-wide Scientific Information System. From data acquisition to advanced interpretation and reporting, UNIFI comprehensively streamlines scientific workflow.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs